Definitive Contract 75A50122C00072
Award Date
9/22/22
Potential Completion Date
9/30/28
Potential Value
$56M
Awardee
Enalare Therapeutics Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $399,990.96 firm fixed price contract awarded to Alamgir Research Inc. (Ariscience) by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract is for R&D on countering opioid respiratory depression using AI-based drug repositioning and in-vitro validation. The work is under AOI #15 REDIRECT and has an ultimate completion date of April 30, 2025. There is no set-aside designation for this award.</p>
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), to Venatorx Pharmaceuticals Inc., a biopharmaceutical company specializing in the discovery and development of novel anti-infective therapeutics. The contract, valued at $147,481,537.00, does not have a set-aside designation and was awarded as a definitive, cost-sharing contract. The work under this contract focuses...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
This federal contract award to Clarivate Analytics (Us) LLC (Clarivate) is for research and development to develop medical countermeasures for chemical threats using drug repositioning. The $749,201 firm-fixed-price contract was awarded on September 20, 2021 by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services. The contract has a period of performance through February 28, 2023 and was issued under a...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Esperovax Inc. a $484,643 firm fixed price definitive contract to develop host-directed therapeutic candidates for mitigating long-term effects of respiratory distress. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought proposals for candidates aiding long-term outcomes from lung injury through Area of...
This is a definitive cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Basilea Pharmaceutica International Ltd, a biopharmaceutical company based in Switzerland. The $85,175,444 contract supports the clinical development of BAL30072, a novel monosulfactam antibiotic for treating infections caused by multidrug-resistant gram-negative bacterial pathogens. This contract is not set aside...
This is a $222,126,308 cost-plus-incentive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development LP, a global contract research organization (CRO). The contract supports a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial in the U.S. to evaluate the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with acute respiratory distress syndrome (ARDS). The contract has an...
This is a $749,447.48 definitive, firm-fixed price contract awarded to Nuvox Pharma, L.L.C., a small disadvantaged business, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for research and development of a novel oxygen therapeutic nanotechnology (NANO2) for the treatment of COVID-19. It extends work from a previous award under Announcement of Opportunity #19. The contract has an ultimate completion...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
This federal contract award, valued at $416,640.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ventolin HFA 1S, a prescription medication used to treat asthma and other respiratory conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...